Brazil's Jair Bolsonaro rocked by scandal over alleged COVID-19 vaccine kickbacks
Brazilian President Jair Bolsonaro already faced a challenging re-election fight, and now political observers are wondering if he'll even be in office still by the 2022 election. The threat to his presidency stems from a congressional investigation into Brazil's haphazard COVID-19 pandemic response. Instead of finding just some mix of incompetence, vaccine skepticism, and sloppiness, the congressional investigation stumbled upon some explosive investigations about kickbacks, financial irregularities, and other corruption allegations that may reach all the way to the president, The Washington Post reports.
The presidency-threatening scandal involves the Brazilian government's decision to hurriedly buy an unapproved COVID-19 vaccine from India's Bharat Biotech at more than 10 times the original quote price, after holding up and haggling over several earlier vaccine offers. Health ministry officials testified that Bolsonaro was informed of the suspected corruption involving the purchase of India's Covaxin vaccine, but he failed to act or notify the appropriate authorities, which could be a crime in Brazil.
"This isn't a suspicion," Sen. Omar Aziz, a leader of the congressional inquiry, told Brazil's O Globo newspaper. "This is a fact. [Bolsonaro] hasn't disproven this. He didn't send anything to the police. ... For any public servant, this would be a dereliction." On Friday, the Supreme Court authorized a criminal investigation into Bolsonaro. The president denied any wrongdoing, claimed he's "incorruptible," then claimed ignorance of the Covaxin deal, and has dismissed the investigation into his actions "an embarrassment."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Bolsonaro's popularity had already taken a hit due to Brazil's COVID-19 pandemic response, which has resulted in both economic pain and more than 500,000 official deaths. Now his approval rating has cratered to the 20s. He "still retains enough political support to fend off calls for his impeachment," but "the belief that Bolsonaro wasn't corrupt has been central to his political survival," the Post reports. "Even as the virus ravaged Brazil, and an increasing number of Brazilians started to blame him for doing little to stop it, he retained his core group of supporters. At least he was honest, many said. Allegations he looked the other way on alleged corruption could undercut one of the few areas of strength he has left."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Are pig-organ transplants becoming a reality?
The Explainer US woman has gene-edited pig-kidney transplant, and scientists hope experimental surgery could save thousands of lives
By Abby Wilson Published
-
Blake Lively's 'bombshell' legal action
In the spotlight It Ends With Us actor files 'astonishing' court filing against co-star and director Justin Baldoni
By Chas Newkey-Burden, The Week UK Published
-
Florida has a sinking condo problem
UNDER THE RADAR Scientists are (cautiously) ringing the alarms over dozens of the Sunshine State's high-end high-rises
By Rafi Schwartz, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published